На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2016
Opioids: Last Week Tonight with John Oliver (HBO)
 
19:23
John Oliver discusses the extent and root of the nation’s epidemic of opioid addiction. Connect with Last Week Tonight online... Subscribe to the Last Week Tonight YouTube channel for more almost news as it almost happens: www.youtube.com/user/LastWeekTonight Find Last Week Tonight on Facebook like your mom would: http://Facebook.com/LastWeekTonight Follow us on Twitter for news about jokes and jokes about news: http://Twitter.com/LastWeekTonight Visit our official site for all that other stuff at once: http://www.hbo.com/lastweektonight
Просмотров: 10815184 LastWeekTonight
Industrys Influence in Medicine: Duped, Doped and Dying in America by Gwen Olsen
 
01:23:54
Expert Panel Host: Gwen Olsen (A podcast version of this video is available on iTunes.) • On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned first hand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. “Gwen Olsen spent fifteen years as a pharmaceutical sales rep working for such healthcare giants as Johnson & Johnson, Bristol-Myers Squibb, and Abbott Laboratories. She enjoyed a successful, fast-paced career until several conscious-altering experiences began awakening her to the dangers lurking in every American medicine cabinet. Her most poignant lessons, however, came as both victim and survivor of life-threatening adverse drug reactions. Gwen Olsen is the author of the award-winning book, Confessions of an Rx Drug Pusher.She is also a contributing author to three books, Drugging Our Children by Dr. Sharna Olfman et al, Doctor of the Futureby Dan Yachter, D.C., and the Maximized Living Makeover Manualby Dr. Ben Lerner et al. Gwen has also published health-related articles in the Well Being Journal, Natural News, and the Health News Digest. Gwen is a passionate mental health activist, writer, and dynamic speaker who devotes much of her time to mental health and child advocacy. Gwen volunteered as a Court Appointed Special Advocate (CASA) for the Travis County court system from 1995 to 2000, serving as an advocate for abused and neglected foster children in Texas. A 2007 Human Rights Award recipient, she is sought after internationally as a speaker and media resource, and has testified numerous times before Congress and the FDA. A fifteen-year-veteran pharmaceutical rep from 1985 – 2000, Gwen worked for McNeil Pharmaceutical, Syntex Laboratories, Bristol-Myers Squibb, Abbott Labs and Forest Laboratories. She was a hospital rep and specialist rep for the majority of her career, educating residents in hospital teaching settings and selling prescription drugs to doctors in obstetrics and gynecology, orthopedics, cardiology, neurology, endocrinology and psychiatry.She has a unique industry insider’s perspective of the current U.S. healthcare dilemma, and utilizes both her experience and the insight she received in her extensive sales training with Pharma to illuminate marketing trends and illustrate how current greed and conflicts of interest make the system itself the biggest health risk to American consumers.”
Просмотров: 10791 The Real Truth About Health
How Much Does A Sales Rep Make
 
05:40
http://adfreewebsite.com - How Much Does a Sales Rep Make Most people looking to step into the sales realm ask, ‘How much does a sales rep make? The simple answer is that the amount can vary between $50,000 to $1,500,000 depending on what path to follow. Instead of asking the question “How much does a sales rep make” the more important question to ask is “what is the opportunity that is being presented?” Four key elements that should shape your decision about the opportunity. 1) Does the market niche have a large group of consumers or customers that are passionate or have a never ending need for the product or service? 2) Is this niche expected to significantly expand in the future? 3) Does the company’s product have a significant advantage when compared to its competitors. Will this advantage allow you to sell it for more money? 4) What is the amount of income that the top sales rep earn in the company and would that be an amount that you would be ecstatic about. There are a multiple options available, probably some you haven’t thought about. Go to our ad free content only website adfreewebsite.com to see what other opportunities are out there. Other url links about How Much Does A Sales Rep Make are: 10 Companies That Pay Salespeople Really Well - Forbes http://www.forbes.com/sites/jacquelynsmith/2011/05/20/10-companies-that-pay-salespeople-really-well/#e7b303e592d2 Forbes May 20, 2011 - On average, sales representatives for wholesalers and manufacturers of technical and scientific products make $84,360 in base salary and commission, according to a Bureau of Labor Statistics survey that reflects salary data from May 2010. Sales Representative Salaries by education, experience, location and ... http://www1.salary.com/Sales-Representative-Salary.html Sales Representative salaries, benefits packages, yearly bonuses, job descriptions, statistics and available ... How much does a Sales Representative make? How Much Should You Pay Your Sales Reps? | PROFITguide.com http://www.profitguide.com/manage-grow/sales-marketing/how-much-should-you-pay-your-salespeople-52411 Profit Jul 17, 2013 - At the highest level, a sales rep might be getting $80,000 or they might get $130,000. So, how do you stop yourself from making a $50,000 ...
Просмотров: 3336 Adfree Website
Top 10 CONSPIRACY Theories About MEDICINE
 
14:30
These days, if you want information, it’s right at your fingertips. In some ways this has been a very good thing. But it’s also given rise to a platform for any insane idea, and for anyone who is trying to make a buck. With all this information so easily accessible, it’s made many of us feel like we’re experts after a little Googling. It doesn’t matter if we have little real familiarity with a subject. This has helped give rise to an industry of hucksters who decry mainstream medicine, touting instead their alternative cures that they will happily supply to you — for the right price. Unfortunately, these con routines have caused a lot of people to distrust mainstream medicine. This distrust has spawned all manner of bizarre conspiracy theories. →Subscribe for new videos every day! https://www.youtube.com/user/toptenznet?sub_confirmation=1 → → GET A T-SHIRT - http://shop.spreadshirt.com/toptenz →Top 10 Objects That Were Clearly Invented Just to Annoy Physics: https://youtu.be/0MVGeRa-vLo →Simon's VLOG: https://www.youtube.com/channel/UCvqt8j7DfPmveJp3UOk9XTg Entertaining and educational top 10 lists from TopTenzNet! Brand new videos 7 days a week! Videos are published at 6pm EST every day! Subscribe to our Facebook: https://www.facebook.com/TopTenz/ Other TopTenz Videos: Top 10 Biggest Health Threats That Get No Attention https://youtu.be/sbDSj8x5CZU?list=PLQ4d2-ByGhnLyDzDNeyvA6ZKu5_jMYMip Top 10 Bizarre New Pills in Development https://youtu.be/Hl6JgxKLut4?list=PLQ4d2-ByGhnLyDzDNeyvA6ZKu5_jMYMip Text version: http://www.toptenz.net/10-kooky-conspiracy-theories-mainstream-medicine.php Coming up: 10. Chemotherapy is a Conspiracy to Make People Sicker 9. Secret Governmental or Medical Powers That Be are Hiding the Cure to AIDS 8. Western Doctors Were Helping Spread Ebola in West Africa as a Test Run 7. Doctors and Hospitals Make People Sicker on Purpose for Repeat Business 6. Pharmaceutical Agencies and Government are Pacifying You with Antidepressants 5. Chemtrails are Making Us Sick to Give Doctors Something to “Treat” 4. The ADA is a Fraud Designed to Harm People 3. SARS was a Biological Attack Test Run Against the Chinese by the USA 2. AIDS was Knowingly Transported Back to the USA by Merck Pharmaceuticals 1. Bird and Swine Flu were Overhyped on Purpose to Gauge the Public’s Reaction Source/Further reading: https://www.sciencebasedmedicine.org/chemotherapy-doesnt-work/ http://www.newdawnmagazine.com/articles/the-secret-origins-of-aids-facts-fallacies-conspiracy-theories http://allafrica.com/stories/201501122455.html http://theconspiracyzone.podcastpeople.com/posts/29612 http://conspiracyanalyst.blogspot.com/2010/09/antidepressants-motives-behind-push.html http://www.express.co.uk/news/weird/684587/CHEMTRAIL-FLU-Doctor-s-shock-claim-planes-make-us-sick-so-medical-firms-can-cash-in http://beforeitsnews.com/conspiracy-theories/2014/02/avoiding-your-dentist-can-save-your-life-2459616.html http://www.sfgate.com/health/article/Outbreak-of-rumors-has-China-reeling-Conspiracy-2618397.php http://www.whiteoutpress.com/timeless/the-confession-that-merck-pharma-created-spread-aids/ http://www.whale.to/vaccine/day4.html
Просмотров: 80272 TopTenz
Healthcare: How To Evaluate Healthcare M&A Deals *** INDUSTRY FOCUS ***
 
19:30
On this episode, Motley Fool analysts explain how to break down biotech mergers and acquisitions. This podcast was recorded on Jan 6, 2016. Imagine owning Amazon.com (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete... Now an industry 99% of us use daily is set to implode... And 3 established companies are positioned to take advantage. Click http://bit.ly/1zQXjzy for a stunning presentation. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: http://www.youtube.com/TheMotleyFool Or, follow our Google+ page: https://plus.google.com/+MotleyFool/posts Inside The Motley Fool: Check out our Culture Blog! http://culture.fool.com Join our Facebook community: https://www.facebook.com/themotleyfool Follow The Motley Fool on Twitter: https://twitter.com/themotleyfool
Просмотров: 908 The Motley Fool
Aspartame Corporation Searle Created First Birth Control: American Eugenics and Big Pharma
 
13:10
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/ Did you know that Aspartame producing corporation Searle also manufactured the first birth control pill? After Donald Rumsfeld was Secretary of Defense under Gerald Ford, he was the CEO of Searle, engineering their merger with Monsanto. A testament to his influence, he became Secretary of Defense again during the Bush Administration, participating in atrocious torture and war crimes such as the ones at Abu Ghraib. One of the most veracious proponents for forced sterilization of blacks, the poor, and "imbeciles," Planned Parenthood founder Margaret Sanger, was a main contributor to what would culminate into Searle's manufacture of "Enovid": the first hormonal birth control pill. This philosophy is commonly known as "eugenics," sometimes referred to as "dysgenics" or "epi-eugenics." Well summarized by the Embryo Project: "Enovid was the first hormonal birth control pill. G.D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories. Although there were many pieces and contributors to the final product, it was first conceived of and created by Gregory Pincus and Margaret Sanger through the Worcester Foundation in Worcester, Massachusetts, and was distributed by Searle, located in Chicago." To illustrate historical ties between "big pharma" and eugenics, let's take a look at the legacy of Dr. John Hurty, an early chemist at Prozac producer Eli Lilly and Company in the 1870's. Hurty would go on to influence the passage of the United States' first mandatory sterilization law, in 1907 Indiana. He was a tireless eugenicist, who believed that the poor, colored people, the disabled, ect. were a burden to the state and society, unfit for reproduction, and should be sterilized. Upwards of 60,000 Americans were involuntarily sterilized through to even the 1970's, while Dr. John Hurty, Margaret Sanger, David Starr Jordan and others made major contributions. Reading from an article by renowned author Edwin Black: "Ultimately, eugenics practitioners coercively sterilized some 60,000 Americans, barred the marriage of thousands, forcibly segregated thousands in "colonies," and persecuted untold numbers in ways we are just learning." Dr. John Hurty, first president of Stanford David Starr Jordan, and Margaret Sanger were members of the scientific, academic class which birthed eugenics, and eventually the world we live in today where Searle had a hand in both birth control, and suspicious toxins such as Aspartame. Reading from this document, which is based on the 1946 book "The Hoosier Health Officer: A Biography of Dr. John N. Hurty": “In 1873, John Newell Hurty went to work for Col. Eli Lilly in his newly established Eli Lilly and Company Pharmaceuticals in Indianapolis as his chief chemist. Then in 1879, Hurty opened his own drug store at the corner of Ohio and Pennsylvania streets. In the basement of that establishment, he set up one of the first analytical laboratories in the state. Among the variety of things he tested for purity was water for the Indianapolis Water Company. In 1884, Dr. Hurty established, and for a time taught at, the School of Pharmacy at Purdue University. In 1891, Hurty earned his medical degree from the Medical College of Indiana. In 1899, Dr. Hurty wrote a bill that became the first comprehensive food and drug legislation to be enacted in the United States. It was not only used as a model by other states, but the Federal Law of 1906 is taken almost word for word from Dr. Hurty’s bill.” This article/video seeks to pose the question: was birth control created as part of eugenics, population control, as part of something that goes beyond money or some alleged philanthropic agenda? Are certain chemicals or pharmaceuticals in circulation designed to fulfill an agenda that goes beyond money, an agenda perhaps that extends into eugenics? Sources: http://www.eraofwisdom.org/aspartame-corporation-searle-created-first-birth-control-american-eugenics-big-pharma/
Просмотров: 869 Era of Wisdom
Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025
 
00:36
Clinical Trials – Discover Commercial Potentials of Outsourced Drug Testing, Benefiting Your Authority What does the future hold for pharmaceutical clinical research providers? Visiongain’s new study gives you multilevel revenue forecasts from 2015 to 2025. It explains trends, opportunities and selling prospects for that drug development and testing. Our report predicts sales at overall world market, submarket and national level. There you find the most promising and lucrative parts of clinical trial outsourcing, helping your research and analysis. That way stay ahead, saving time and hassle, also benefiting your influence. Clinical research organisations (CROs) and drug companies using them will benefit from expansion of that industry and market. Those technologies and outsourced services hold rising importance in pharmaceutical R&D. See why and how, finding the gains possible. Read on, then, to explore those contracting services for benefiting medicine. Find what influences that market and see predicted revenue. Forecasts and other analyses to help you stay ahead in knowledge Why struggle to find information or miss data you need on clinical outsourcing and off-shoring? Instead reduce worry there, helping your searches, proposals and presentations. So in our work discover where the money lies, and best places for business expansion. In that study you explore revenue forecasting to 2025, results and other statistics, growth rates, leading companies and market shares. You also assess qualitative analysis (SWOT and STEP), news, business progress, outlooks and developmental needs – pharma R&D trends and demands. You find expected gains. There you get 78 tables, 65 charts and interviews with three companies. The clinical testing market will increase its revenues from 2015 to 2025, achieving strong sales expansion. Our survey’s purpose is to explain those needs, opportunities and potentials. For an Executive Summary of this report please contact sara.peerun@visiongainglobal.com (+44 (0) 20 7336 6100) or refer to our website: https://www.visiongain.com/Report/1458/Pharma-Clinical-Trial-Services-World-Industry-and-Market-Prospects-2015-2025
Просмотров: 66 visiongain
12 Cities With The Highest Number Of Billionaires
 
07:31
12. Tokyo – 16 Billionaires Tokyo has 16 billionaires who call the city home. However, Tokyo was also the city with the most millionaires by the end of 2012, and most of the millionaires in the city made at least $30 million. There are currently about 26 billionaires in the city of Tokyo, and they make an average of $71 billion. Tokyo is the leading industrial city in Japan, and there are a number of management and finance centers in the area. 11. Los Angeles – 22 Billionaires Whether you’re looking at Los Angeles County or Orange County and the surrounding neighborhoods, it’s safe to say there are a number of billionaires in Los Angeles. 22 to be exact. There are also several different ways that these successful businesspeople make their money. They include Patrick Soon-Shiong, who is worth around $8 billion, and made his money selling two major drug companies. 10. Sao Paolo – 25 Billionaires Sao Paolo is home to a number of telecommunications and automotive companies. The city is also well known for its pharmaceutical, beauty and fashion industries. Clearly, there are lots of ways to become a billionaire in Sao Paolo that don’t involve tourism, even though the city does make a significant amount of money from vacationers who visit there. 9. Istanbul – 28 Billionaires The city of Istanbul is home to about 28 billionaires. The net worth of the billionaires is around $48.7 billion, and the average billionaire in the city has a net worth of $1.62 billion. Istanbul is considered one of the “poorer” cities in the world, but the income of these wealthy individuals is still more than most people could dream of making. 8. Seoul – 29 Billionaires Tourism and computers are big business in Seoul, and there are also various aspects of the technology industry that are thriving in the city as well. Some of the wealthiest individuals in Seoul include Lee Seo-Hyun, who is a prominent businesswoman in the computer and tourism industries. 7. Mumbai – 33 Billionaires Mumbai is home to 33 of the 68 billionaires who live in India. The Knight Frank Wealth Report for 2015 also ranked Mumbai number 6 on the list of 20 cities around the world. The report also indicates that wealth in India is expected to double over the next ten years. Real estate companies, as well as restaurants and software companies, are prevalent in Mumbai. There are also major banks in the city, as well as entertainment companies . 6. Dubai – 34 Billionaires According to Forbes, about one-third of the richest people in the Middle East are related to each other. This just goes to show how beneficial it is for people to learn financial management tips from their older family members. Sheikh Ahmed Bin Saeed Al Makthoum is among Dubai’s richest men, and he was born into the royal family (he is the son of the former ruler of Dubai). He is worth around $18 billion. 5. Beijing – 45 Billionaires About 1% of the people living in China are billionaires from Beijing. 45 to be exact. Since the stock market crash, it’s been a bigger challenge to be so wealthy and manage funds properly. The anti-corruption campaign in the country has also made it more challenging for party leaders to acquire and maintain wealth. Some of the richest people in Beijing include Zhang Xin and Pan Shi Yi, who are likely the biggest commercial property developers in the country of China. 4. London – 46 Billionaires 46 of the world’s billionaires live in London. Their average net worth is around $133.7 billion, and the average London billionaire makes $3.43 billion. There are also some reports that the number of billionaires in London has more than doubled, as some sources say that around 80 people who are billionaires call the city home. 3. Hong Kong – 64 Billionaires Hong Kong has a number of wealthy individuals, and a number of them have made their money in real estate. Of course, there are several booming industries in the city, so some of the billionaires and millionaires there have also acquired their fortunes through diversified interests. 2. Moscow – 68 Billionaires When it comes to money in Moscow, names like Alisher Usmanov and Viktor Vekselberg come to mind. These men are both self-made billionaires, and have large companies and business deals to prove how savvy they are with money. 1. New York City – 78 Billionaires As of 2015, New York City has 78 billionaires, which is more than any other city in the entire world. Those who have lots of cash in the city include Michael Bloomberg, who is the former mayor of the city. Source- http://www.therichest.com/rich-list/the-biggest/12-cities-with-the-highest-number-of-billionaires/ music - Future Cha Cha by Kevin MacLeod is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100374 Artist: http://incompetech.com/
Просмотров: 3951 Top10 Ever
United States Tablet Computers Market Report 2016
 
00:26
This report studies sales (consumption) of Tablet Computers in United States market, focuses on the top players, with sales, price, revenue and market share for each player
Просмотров: 8 Swaraj Nanda
How This $1.6 Billion Company May Change A $10 Billion Market
 
06:06
Demand for a new class of anticoagulants is soaring, but sales of them could climb even higher if Portola Pharmaceuticals antidote wins FDA approval this year. This podcast was recorded on Feb. 24, 2016. Imagine owning Amazon.com (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete... Now an industry 99% of us use daily is set to implode... And 3 established companies are positioned to take advantage. Click http://bit.ly/1zQXjzy for a stunning presentation. ------------------------------------------------------------------------ Subscribe to The Motley Fool's YouTube Channel: http://www.youtube.com/TheMotleyFool Or, follow our Google+ page: https://plus.google.com/+MotleyFool/posts Inside The Motley Fool: Check out our Culture Blog! http://culture.fool.com Join our Facebook community: https://www.facebook.com/themotleyfool Follow The Motley Fool on Twitter: https://twitter.com/themotleyfool
Просмотров: 555 The Motley Fool
Europe to Crash First, then US: Immigration & Currency Crisis - John Rubino Interview
 
29:34
This Energy Stock is a Lottery Ticket for Technological Revolution: http://CrushTheStreet.com/Tech2016 GUEST: http://DollarCollapse.com John Rubino is a frequent and popular guest, see more interviews from us with him here: http://www.crushthestreet.com/tag/john-rubino
Просмотров: 24999 FutureMoneyTrends.com
The Most Profitable Company In The US Didn't Top The Fortune 500 List
 
01:20
This year marks Fortune magazine's 62nd annual ranking of the U.S.' 500 largest companies. Combined, this year's contenders earned $12 trillion in revenues. Wal-Mart once again tops the Fortune 500 list, which was released Monday.  Wal-Mart boasts the second-largest online revenue among American companies. And Fortune reports Wal-Mart earned $482 billion in total revenue last year.  Still, the company's total revenue in 2015 decreased for the first time in roughly 45 years.  Wal-Mart blamed the drop in sales on store closures and currency exchange rates.  Ranking second on the Fortune 500 list was oil and gas company Exxon Mobil, whose total revenue numbers were about half that of Wal-Mart.  And Apple was ranked third this year, despite actually being the most profitable company on the list. It made more than $53 billion in profits in 2015; however, Fortune's list is based on revenue.  Warren Buffett's Berkshire Hathaway and pharmaceutical distributor McKesson placed fourth and fifth, respectively, though Fortune seemed to hint that McKesson might not remain in that coveted spot next year if Walgreens ends up acquiring Rite Aid, which has a distribution deal with the company.  UnitedHealth Group, CVS Health, General Motors, Ford Motor and AT&T round out the list's top 10.  Other notable companies to make the Fortune 500 list include Amazon, Boeing, Wells Fargo, Target and Starbucks. Even Campbell's Soup earned a spot, coming in at No. 337.  For more details on the rankings, head on over to Fortune's website.  This video includes clips from Wal-Mart, Apple and Walgreens and images from Getty Images. Music provided courtesy of APM Music. Newsy is your source for concise, unbiased video news and analysis covering the top stories from around the world. With persistent curiosity and no agenda, we strive to fuel meaningful conversations by highlighting multiple sides of every story. Newsy delivers the news and perspective you need without the hype and bias common to many news sources. See more at http://www.newsy.com/ Like Newsy on Facebook: http://www.facebook.com/newsyvideos/
Просмотров: 2549 Newsy
Pharmaceutical In India
 
02:51
Просмотров: 19 Huing Ilissa
McCaskill: This Business Model Uses Patients as Hostages
 
01:32
U.S. Senator Claire McCaskill sharply questioned officials and investors of Valeant Pharmaceuticals about the company’s business strategy—which relied upon aggressive corporate acquisitions and price hikes. The hearing also included testimony from individuals and experts who explained the negative impact for individuals caught in Valeant’s ‘price-gouging’ practices. “You can try to dress up this business model with good sounding phrases but (the model) is simple...give the companies that develop a drug that has little to no competition a healthy profit, fire the scientists, and jack up the prices as high as you think you can get away with,” McCaskill said. “It’s using patients as hostages. It's immoral. It hurts real people. It makes Americans very very angry. In case you haven't noticed that has real ramifications in our political process and could lead to an instability of our government, our economy, and our standing in the world. Pigs get fed, hogs get slaughtered. It's time to slaughter some hogs.” Valeant consistently acquired pharmaceutical companies that were the only producer of off-patent drugs, often then slashing the research and development spending for those companies and raising the prices on their recently-acquired drugs by hundreds or thousands of percentage points. Valeant’s entire research and development budget was consistently below 5 percent of their total sales—dramatically lower than most other companies in the pharmaceutical industry. One of the witnesses Berna Heyman, who had lost access to the drug Syrine, which is used to treat Wilson’s disease after a dramatic and sudden price increase said, “I’m very proud to see this (hearing) in action. That the committee agreed to look at this issue is doing something for so many of us.”
Просмотров: 583 Senator Claire McCaskill
52% of Doctor's High on Street Drugs and Pharmaceuticals? [9/26/16] Audio Podcast
 
27:53
Dr. Joel Wallach begins the show discussing medical statistics. Stating that according to a study done by Lucian Leape found that 52% of doctors tested were high on street drugs, pharmaceuticals or alcohol. Asserting that recent government statistics show that medical mistakes are now the third leading cause of death in the U.S. Pearls of Wisdom Doug Winfrey and Dr. Wallach discuss a news article concerning a study of gut inflammation. Using lab equipment that simulates a human intestinal tract complete with gut bacteria. Researchers then added emulsifiers that are commonly added to processed foods to extend shelf life. Then noting a dramatic increase in a marker of gut inflammation. Then gave the emulsifiers to mice which developed gut inflammation. This inflammation can lead to chronic conditions like obesity, high blood sugar and insulin resistance. Callers Bertie has friend diagnosed with left ventricular non-compaction syndrome. Teresa has allergies to several things. Thomas has questions regarding his mother-in-law who has high blood pressure, arthritis and atrial fibrillation. Sherry has dog with cancerous nodules in it's lungs. Marylou has arthritis kidney disease and hypertension.
Просмотров: 236 fawkes1570
How Adderall & Ritalin Work
 
06:30
This research was published in the U.S. National Institutes of Health’s National Library of Medicine(NIH/NLM): ***One should only use these stimulants (Adderall, Ritalin, Concerta or Vyvanse) if prescribed by their physician. Recreational use is prohibited & the risk for potential abuse of these drugs is extremely high.*** Scientists Explore Twitter for Non-Medical Use of Adderall: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636321/ Case Report: Testicular failure possibly associated with chronic use of methylphenidate (Ritalin): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215747/ Potential Adverse Effects of Amphetamine Treatment on Brain and Behavior: A Review: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670101/ Understanding the Risk of Using Medications for ADHD with Respect to Physical Growth and Cardiovascular Function: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408826/ Influence of amphetamines on plasma corticosteroid & growth hormone levels in man: http://www.ncbi.nlm.nih.gov/pubmed/4311188 DEA classification of Methylphenidates: http://www.dea.gov/druginfo/concern_meth.shtml DEA classification of Adderal, Ritalin, Cocaine, Vicodin, Methamphetamine & Oxycontin: http://www.dea.gov/druginfo/ds.shtml Adderall Sales Numbers according to the IMS: http://www.huffingtonpost.com/2013/12/17/adderall-charts_n_4459341.html Animations & script inspired by: Reaction - How Does Adderall(TM) work: https://www.youtube.com/watch?v=MeJRBsghMt8 Welcome to episode 2 of MEDspirational Science! This week's episode discusses the impact that long term Adderall & Ritalin use can have on our physiology & overall health. The prevalence of stimulant use (medically & non-medically) in college & post-graduate programs continues to sky rocket! Student's have compared stimulants such as Adderall, Ritalin, Vyvanse & Concerta to performance enhancing drugs in athletes - claiming that they can work as a sort of cognitive steroid that enhances mental focus & therefore increases their ability to cram before a test. Today we explore these claims & take an in depth look at how these drugs work in the human body! Subscribe & become a part of the healthiest family on YouTube! Available on Instagram: https://www.instagram.com/medspiration Available on FB: https://www.facebook.com/MEDspiration Available on Twitter: https://twitter.com/medspiration_ Booking & charity inquires: medspiration@gmail.com
Просмотров: 61465 MEDspiration®
Global Pharmaceutical Anti-Counterfeiting Technologies Consumption Industry 2016 Market Research
 
00:31
The Global Pharmaceutical Anti-Counterfeiting Technologies Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pharmaceutical Anti-Counterfeiting Technologies market. First, the report provides a basic overview of the Pharmaceutical Anti-Counterfeiting Technologies industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Pharmaceutical Anti-Counterfeiting Technologies market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Get Discount on This Report: http://www.researchnreports.com/ask_for_discount.php?id=3149 Third, the Pharmaceutical Anti-Counterfeiting Technologies market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What?s more, the Pharmaceutical Anti-Counterfeiting Technologies industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Complete Report Available at: http://www.researchnreports.com/pharma-healthcare/Global-Pharmaceutical-Anti-Counterfeiting-Technologies-Consumption-2016-Market-Research-Report-3149
Просмотров: 3 vil Kudl
Tildatech Pharma-Track Highlights Code of compliance software solution for Pharmaceutical companies2
 
01:37
For more email us on info@tildatech.co.za Or call on: 011 823 6773 See more: Informal Meeting and Approval Process Demo https://youtu.be/J8lu4K1rArQ Read more...Case Study: http://www.tildatech.co.za/Downloads/CaseStudy-AspenPharmacareSA-RepAssist.pdf Read more...Press Release: http://www.tildatech.co.za/PressReleaseJune2015.aspx As a code of compliance software solution developed by Tilda Technologies, Pharma-Track, created for pharmaceutical companies, not only, captures, tracks and monitors the Informal and Formal meeting approval process in line with the South African marketing code of practice, as set out by the marketing Code Authority, but it also improves turnaround times. Website: www.tildatech.co.za
Просмотров: 65 Tildatech
How to Build a Forecasting Model in Excel - Tutorial | Corporate Finance Institute
 
19:24
How to Build a Forecasting Model in Excel - Tutorial | Corporate Finance Institute Enroll in the Full course to earn your certificate and advance your career: http://courses.corporatefinanceinstitute.com/courses/fpa-rolling-12-month-cash-flow-forecast-course Master the art of building a rolling 12-month cash flow forecast model in our Financial Planning & Analysis (FP&A) course. In this course you will learn to build a cash flow model from scratch complete with assumptions, financials, supporting schedules and charts. -- FREE COURSES & CERTIFICATES -- Enroll in our FREE online courses and earn industry-recognized certificates to advance your career: ► Introduction to Corporate Finance: https://courses.corporatefinanceinstitute.com/courses/introduction-to-corporate-finance ► Excel Crash Course: https://courses.corporatefinanceinstitute.com/courses/free-excel-crash-course-for-finance ► Accounting Fundamentals: https://courses.corporatefinanceinstitute.com/courses/learn-accounting-fundamentals-corporate-finance ► Reading Financial Statements: https://courses.corporatefinanceinstitute.com/courses/learn-to-read-financial-statements-free-course ► Fixed Income Fundamentals: https://courses.corporatefinanceinstitute.com/courses/introduction-to-fixed-income -- ABOUT CORPORATE FINANCE INSTITUTE -- CFI is a leading global provider of online financial modeling and valuation courses for financial analysts. Our programs and certifications have been delivered to thousands of individuals at the top universities, investment banks, accounting firms and operating companies in the world. By taking our courses you can expect to learn industry-leading best practices from professional Wall Street trainers. Our courses are extremely practical with step-by-step instructions to help you become a first class financial analyst. Explore CFI courses: https://courses.corporatefinanceinstitute.com/collections -- JOIN US ON SOCIAL MEDIA -- LinkedIn: https://www.linkedin.com/company/corporate-finance-institute-cfi- Facebook: https://www.facebook.com/corporatefinanceinstitute.cfi Instagram: https://www.instagram.com/corporatefinanceinstitute Google+: https://plus.google.com/+Corporatefinanceinstitute-CFI YouTube: https://www.youtube.com/c/Corporatefinanceinstitute-CFI
Просмотров: 107228 Corporate Finance Institute
PCD Pharma Franchise
 
01:21
Apikos Pharma is a rapidly growing PCD and pharma franchise company in India. Being an ISO 9001:2008 global pharmaceutical company, we offer a vast product range consisting of tablets, capsules, syrups, injections, protein supplements and Ayurvedic products, all approved by Drug Controller General of India (DCGI). From raw materials to processed drugs, we always comply with the industry standards to deliver high quality, pure and effective products to the society. Our Products offer not only higher margins but also ensures quality with timely deliveries. We are interested in direct supplies to whole sale chemists, pharma distributors/ stockist, Medical Representatives/ Area Sales Manager/ Regional Sales Manager for ethical promotion of our quality product range. We have in our portfolio, a wide range of products, either different in formulations or having advance technology & having certain U.S.Ps. (Unique selling propositions) which keeps our brand above the mushrooms of many "ME Too's" in the market. To become a reputed Pharmaceutical Company in India in sphere of excellence and quality products and be the first choice of every customer by providing them value for money. If you are interested in operating as a franchise anywhere or in unrepresented India, then get in touch at the below mentioned contact numbers - +91-9855087879 for: Franchise Opportunity/Pharma PCD/ Pharma Franchise/ Pharma PCD Franchise pikos Pharma is headed by Mr. Harish Sharma and Mr. Anil kapoor who had rich experience of pharmaceutical industry at different level in management category in various reputed companies. There able guidance has propelled us to a prominent position in this highly competitive industry and their quality driven approach inspires us to provide our partner the best products in the market. Apikos Pharma is a ISO 9001-2008 Certified Chandigarh based pharmaceutical company having operation in all over India. Apikos Pharma is with a powerful combination of skills, resources and our support system that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Просмотров: 5188 apikos pharma
Fentanyl: The Drug Deadlier than Heroin
 
52:09
VICE presents an immersive and personal feature film about the fentanyl crisis in Canada told from the perspective of a community of drug users. This video has been edited from its original version due to privacy concerns surrounding one of its subjects. WATCH NEXT: Black Widow: Dominating the Masculine World of Boxing: http://bit.ly/28UgNhS Watch more of our documentaries on drugs: http://bit.ly/2aB0DuG Click here to subscribe to VICE: http://bit.ly/Subscribe-to-VICE Check out our full video catalog: http://bit.ly/VICE-Videos Videos, daily editorial and more: http://vice.com More videos from the VICE network: https://www.fb.com/vicevideo Like VICE on Facebook: http://fb.com/vice Follow VICE on Twitter: http://twitter.com/vice Read our Tumblr: http://vicemag.tumblr.com Follow us on Instagram: http://instagram.com/vice Check out our Pinterest: https://pinterest.com/vicemag
Просмотров: 6907783 VICE
How Top Companies Develop Product Launch Messaging
 
29:25
Today’s topic is Product Launch and Messaging. Joining us is Rob Lips, Vice President of U.S. Sales and Channel Marketing at Intuit. Rob lead sales, channel marketing and analytics across Intuit’s retail, e-tail, inside sales, resellers, OEMs and financial Institutions. He is responsible for a +$900M business with a team of over 500 people. Product launches fail to generate revenue when sales people and channel partners are not involved in messaging development during prelaunch preparations. When messaging is developed in isolation it is not compelling enough to get your customers to act. Stories told directly to customers by well-trained sales channels enable customers and prospects to answer “Why change?” and this stimulates latent demand while leading to exceptional revenue growth. Watch as Rob talks through the messaging and storytelling approach based on his experience of successfully launching many products. Success requires sales reps to defeat the status quo. Rob explains how to develop and roll-out messaging where sales can tell stories about somebody else who in a similar situation took the plunge, and how they used your products and services to get to a better outcome.
Просмотров: 256 SBI TV
Jon Rappoport, Dr. Sherri Tenpenny & Andreas Bachmair - Zika Virus “Outbreak”...
 
59:10
Jon Rappoport, Dr. Sherri Tenpenny & Andreas Bachmair - Zika Virus “Outbreak” & The Vaccine Industry - Hour 1 Jon Rappoport has worked as a free-lance investigative reporter for over 30 years. He is the author of several books, including “AIDS, Inc.: Scandal of the Century.” He is behind the website NoMoreFakeNews.com. Dr. Sherri J. Tenpenny, founder of Tenpenny Integrative Medical Center in Middleburg, Ohio, has been board certified in Osteopathic Manipulative Medicine since 1995. She has written two best-selling books, “FOWL! Bird Flu: It’s Not What You Think” and “Saying No To Vaccines: A Resource Guide for All Ages.” Andreas Bachmair is a German homeopath physician with a practice in Kreuzlingen, Switzerland. The focus of his work for over a decade has been the treatment of vaccine-related injuries. This led him to create the website VaccineInjury.info. He is also the author of the newly released book, “Sarah Doesn’t Want to be Vaccinated.” Our three returning guests join us for a discussion on the dangerous affair of vaccines and the misleading propaganda being peddled by infectious disease agencies. We begin with an in-depth look into the latest “outbreak” hysteria centered on Zika, where the main controversy of the mosquito born virus cropping up in Brazil is being linked to microcephaly in newborn babies by the World Health Organization. Jon gives the generalities of the fraudulent science backing the WHO’s claims and he explains how this scare is being used as a psyop to cover up another serious problem. Sherri talks about the recent MMR vaccine campaign that led to the re-vaccination of around 39,000 women of child bearing age in Brazil, and she lays out how the Zika virus being labeled as an international emergency could allow an epic opportunity for the big-pharma-funded FDA to roll out a mass utilization of untested vaccinations. In addition, we get into the incestuous affairs of the “virus hunter” branch of the CDC, along with their ties to the mainstream press and the giant pesticide corporations that are making big bucks in Brazil. In the members’ segment, we address some of the foundations of the vast vaccine debate. Andreas talks about the online survey he’s been collecting for over five years in order to study different illnesses in unvaccinated vs. vaccinated children. We consider the 1.3 trillion dollar worldwide pharmaceutical industry’s cornerstone business of vaccine production and the scam statistics that keep these toxic concoctions flowing through the medical marketplace. Then, we discuss the immune system’s natural defense mechanisms, the false premise that humans should never get sick, and the benefits of naturally occurring of childhood diseases. We put focus on the deadly HPV vaccine, Gardasil, and the horrible implications that this reproductive system destroying inoculation is another device to stop the growth of certain populations. Further, we deliberate the huge moneymaking scam of the National Cancer Institute’s futile attempts to find a link between viruses and cancer. The conversation rounds off with a look at the deeper issue of why vaccines are falsely promoted as protection for the young, the old, and the chronically ill. Guest's Websites: nomorefakenews.com jonrappoport.wordpress.com drtenpenny.com tenpennyimc.com vaccineresearchlibrary.com Listen to the second hour of this show and get full access to our archives: http://redicemembers.com Subscribe and stream or download over 1000 programs on all the topics you are not supposed to know about. More Red Ice Radio: http://redicecreations.com http://rediceradio.net Follow us on Twitter: http://twitter.com/rediceradio Like us on Facebook: http://facebook.com/RedIceCreations Listen on Soundcloud: https://soundcloud.com/red-ice-radio RSS feeds: http://redicecreations.com/rss.php
Просмотров: 8298 Red Ice TV
Documentary showing the fake pharmaceutical medication industry
 
44:00
When you get cheap medicines,medications, pills, be it through a vendor, online or a friend, it's not always not what you expect. Fake pharmaceutical, pills, what is in them, the risks. Need advise on health, alternate medication or wan organic health supplement made from organic ingredients specifically for your lifestyle and conditions. Contact us for a free consultation. We are a full-service organization providing services including technology and communications, Health and Wellness, Business Services, Psychological Services, Design and Creative services, media and information services and a lot more. If you would like a free consultation so that we can discuss with you how we can help you, your organization or even your family, contact us on one of the methods below no matter where on the planet you are just make sure to give us a landline or a Skype Id an email address, as well as the times that you're available and the best time to contact you. We will email you a confirmation time and the name of the Consultant who will discuss the best services for you. Contact details Skype : sjsmithonline.com Email : cs@sjsmithonline.com / sjsmithonline78@gmail.com Hangouts: sjsmithonline78@gmail.com Facebook: https://www.facebook.com/sjsmithonline Our Websites http://www.sjsmithonline.com/ http://www.sjspcsupport.com/ http://www.seniorssupport.org/
Просмотров: 94 SJ Smith
SAS Training Beginners Must Watch Video
 
13:01
SAS Training Beginners Must Know What is SAS? SAS Online Training For SAS Programming with SAS Software Tutorials For SAS Certification and SAS jobs. SAS Full Form Is Statistical Analysis System/software. SAS Training at http://www.eduemaster.com/ makes students proficient in SAS .It provides Base SAS, Advance SAS,SQL, Macros, Clinical SAS(CDISC) training. SAS Training will be provided by certified trainers having above 6 years real time experience. Training will be in such a way that even a layman can understand. Register For Live Demo: http://www.eduemaster.com/contact-us/ Mail : contact@eduemaster.com Whatsapp : +91 9912025945 , +44 7760860100 Phone : IND +91 9912025945 U.S.A + 1 (917)-310-3073 U.K +44 7760860100
Просмотров: 29544 SAS Online Training
Cadila pharma is suggested for buying | Stocks Fast 50
 
04:41
Cadila pharma is suggested for buying with the news of its permission for selling generic drug of Asacol in US. Watch complete news story of Stocks Fast 50 and stay updated with the latest trends and statistics in the stock market, commodity market and share market! Zee Business is one of the leading and fastest growing Hindi business news channels in India. The channel has revolutionized business news by its innovative programming and path-breaking strategy of making business news a 24/7 activity as it is not just limited to the stock market. This has made Zee Business your channel to wealth and profit. Besides updated hourly news bulletins, there is a lot to watch out for, whether it be stock market related detailed information, investments, mutual funds, corporate, real estate, travel or leisure. The channel has the most diverse programming portfolio which has positioned it as a channel of choice amongst viewers. By speaking a language of the masses, Zee Business is today the most preferred for business news. Some of the popular shows of Zee Business are: Share Bazar, Mandi Live, Aap Ka Bazar, First Trade, Big Debate etc.
Просмотров: 170 ZeeBusiness
Janus Forum "What if the US Legalized All Drugs?"
 
01:37:10
Janus Forum Lecture Series, Brown University "What if the US Legalized All Drugs?" Featured speakers: Glenn Greenwald and John P Walters Thursday, November 10, 2011
Просмотров: 5424 Brown University
Cocaine production explained
 
02:41
This motion graphic is intended to provide an indicative schematic overview of selected stages of a production process. It must be noted that alternative methods, chemicals and procedures may exist. Read more about drug production and drug markets in the upcoming EU Drug Markets Report on 5 April 2016: http://www.emcdda.europa.eu/start/2016/drug-markets Music: Des Xavier, Butterfly (Creative Commons Attribution-NonCommercial-NoDerivs Licence - http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode).
Просмотров: 64483 EMCDDA
Global  Ophthalmic Drug Consumption Industry 2016 Market Forecasts to 2021
 
00:31
The Global Ophthalmic Drug Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Ophthalmic Drug market. First, the report provides a basic overview of the Ophthalmic Drug industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Ophthalmic Drug market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Get Discount on This Report: http://www.researchnreports.com/ask_for_discount.php?id=3147 Third, the Ophthalmic Drug market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What?s more, the Ophthalmic Drug industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Complete Report Available at: http://www.researchnreports.com/pharma-healthcare/Global-Ophthalmic-Drug-Consumption-2016-Market-Research-Report-3147
Просмотров: 2 vil Kudl
A Good Start To FY17 For Auto Companies
 
03:51
Its been a good start to the new financial year for most auto makers so be it country's largest carmaker Maruti's who's new launches have ensured that a dip in exports in April has been more than compensated by a massive jump in the utility vehicles space. Or tractor sales for Escorts and Mahindra and Mahindra there's nothing much to complain about. The only company to miss the bus is Bajaj Auto who's total sales continue to dip on a year on year basis. Farah Bookwala Vhora gives us a comprehensive analysis of the numbers.
Просмотров: 57 CNBC-TV18
ATTENTION Pharmaceutical Professionals
 
03:11
http://pharmaceutical-compliance.com/ “What Will You Do When Your Business Is Shut Down – Or You’re Thrown Into Prison – Because Your Compliance Isn’t Up To Date?” If you want to get licensed to sell your products in the UK and EU, but don't know how to get them to market, then this could be the most important video you watch all year – here’s why… Selling your products in U.K. and E.U. markets can be highly lucrative, and may be something you’re either already doing or seriously considering. But are you certain that you’re complying with every single regulation? With dozens of new laws passed every year and regular changes to existing ones, the answer is almost certainly ‘no’, and if you aren’t properly covered you could be storing up huge problems for the future. So you need to know exactly what you’re doing, otherwise you could be liable for prosecution. That’s right: with potentially unlimited fines, closure of your company premises, and even possible manslaughter charges and long prison sentences for non-compliance. But that’s not all – from April 2016 a new law comes into force, which makes regulatory compliance the joint responsibility of the Qualified Person AND the company, and increases the risk profile for your business. Plus there’s also trademark legislation to consider… That’s the bad news: the good news is there’s now a quick and easy way to make sure you’re fully compliant with all the relevant laws and regulations, without it costing you a fortune. And that’s where I can help you… My name is Paul Palmer. I’m a pharmaceutically Qualified Person and my company offers a comprehensive ‘done-for-you’ service to managing directors, quality directors and commercial teams looking to sell their pharmaceutical products in the U.K. and E.U. markets, dealing with issues such as Batch Release, regulatory compliance, reviewing existing working practices and QP declarations To help you understand what’s involved in bringing your product to the U.K. and E.U. markets, I’d like to offer you a free online copy of my new guide. It’s called ‘How To Get Your Product To Market’ and includes: • A coherent plan for how to get your product to market (based on your company’s requirements) • An overview of the regulations and legislation you’ll need to comply with (essential for keeping you in profit and out of the law courts) • A list of the key processes to be put in place (to streamline your operations and get rid of any logistical headaches), and much more… To claim your free copy of this guide, please complete the form on this page and click on the send button. However, this offer is time-limited and only open for a short time. So please make sure you respond today, otherwise you’ll miss out…http://pharmaceutical-compliance.com/
Просмотров: 48 QP Solutions
How to Compensate a Salesperson for your Property Management Company | The Property Management Show
 
31:15
How long did it take you to get to 300 doors? - It took about three years. I decided to hire someone because I was a good salesperson but not a great one, and I was doing business development and sales 10 to 20 percent of the time during the day. I knew if I could find someone to do it better than me full-time, I would grow. I was averaging 100 units a year when it was just me, and then when I brought in a salesperson, that growth went to 300-plus units a year.. WEBSITE: http://everythingpropertymanagement.com/ Property Management Marketing: http://fourandhalf.com How to Compensate a Property Management Salesperson The topic today is how to compensate a salesperson for your property management company. If we have a chance, we’ll talk about when you should hire that salesperson and shed some light on how to find and interview and retain the best salespeople for your property management shop. Our guest is Duke Dodson who runs Dodson Property Management. He has one of the fastest growing property management companies in the U.S., and he’s uniquely positioned to talk about this. Q: Thanks for joining us, Duke. Tell us a little about your company and your story. When did you first decide to hire a salesperson? How far along were you in your growth trajectory? A: I started my company in 2007. It was just me, so I was the business development person and the salesperson. When I got to the point that we had 300 units under management, I hired the first salesperson. Q: There is something to be said about setting up systems to be able to accept this kind of growth. For most property managers, growing by 10 properties a month is a good goal. So 300 a year is a great launching pad. I don’t know of any information in NARPM or the general property management industry that talks about sales compensation. So how did you come up with a strategy? A: There was no roadmap early on, so I had to make it up. I looked at the type of person I wanted in the role and then I had to figure out the compensation model that person would be comfortable with. It’s rare to find someone with property management experience and sales experience. So unless you’re going to poach this person from another company, it’s going to be difficult for a property manager to find a salesperson with experience in single family management. I looked at other salespeople I might want to attract. Pharmaceutical and medical sales seemed the way to go because these are high energy, results-driven professionals. So I looked at those models. Some had a small salary plus commission and others worked solely on commission. I liked those models. So with our first salesperson, I provided a straight commission and no salary. I built it so that if he did well in the first year, then his compensation would increase in the second, third and fourth years, so it would be hard to walk away. He could earn a great income if he performed. Q: So you used a recurring compensation plan. He got to eat a bit of what he killed over time and each account brought him a percentage. A: Right, if he brought in a single family home for us to manage, he earned 25 percent of all the revenue associated with that property for one year. Then if he retained the property under our management in year 2 and 3, he’d continue to earn 15 percent. In year four, the commission would drop off. Q: That’s a lot of money. A: I learned that the industry standard was similar to that, and I also learned that you get what you pay for. If you want that top notch rainmaker, they will need to make a good living and you’ll have to compensate appropriately. But you may not need a rainmaker. If you’re getting a lot of warm leads from SEO and content, you don’t necessarily need a rainmaker, you need someone with good sales structure and organizational skills who can do presentations. That person doesn’t need to make $150,000 a year. You’ll find a good salesperson who can earn $60,000 or $80,000 a year. If you’re paying high rainmaker numbers, make sure they are bringing in a lot of business. Q: So for a younger company, it made sense to pay your salesperson a full commission of 25 percent
Просмотров: 894 The Property Management Show
Hamza Yusuf American Muslim Scholar speaking on Vaccines
 
16:54
An Influential American Muslim Scholar speaking on Vaccines, Health, and Prophetic Medicine and giving great advice to medical doctors and anyone who practices medicine, Watch video! "There are unanswered questions about vaccine safety... No one should be threatened by the pursuit of this knowledge." "I think public health officials have been too quick to dismiss the hypothesis as irrational without sufficient studies of causation." - Dr. Bernadine Healy, MD (Former Director, National Institute of Health and Former President, American Red Cross) Dr. Tony Morris, MD "There is a great deal of evidence to prove that immunization of children does more harm than good." "The manufacturers of these vaccines know they are worthless but they go on selling them anyway." - Dr. J Anthony Morris, Ph.D. (Former Chief Vaccine Control Officer and Research Virologist, US FDA) "Crib death was so infrequent in the pre-vaccination era that it was not even mentioned in the statistics, but it started to climb in the 1950s with the spread of mass vaccination." - Dr. Harris L Coulter, PhD Hear from more Doctors, Scientists, and Experts who put their future on the line to bring us the Truth it's worth hearing what they have to say, getting informed and having a choice in the matter not based on ignorance, fear or intimidation. http://vaccine-injury.info/ The United States has more vaccines on the childhood schedule than any other developed country, yet we have one of the sickest populations — despite spending more on healthcare than any other developed country. We are exposed to a chemical cocktail from polluted air and water, processed food laced with toxins and pesticides, and then we add vaccines to the mix. Vaccines contain multiple additives that have no place in the human body. Chemicals that are injected and therefore bypass the body’s natural filters. Chemicals and additives that go straight to the vital organs causing numerous issues that have somehow become the new ‘normal’ in our country. Everybody is different. We each have different chemical thresholds and processing abilities. Chemicals and heavy metals accumulate, and you can never know what will tip the balance for someone and lead to health issues—sometimes serious, lifelong problems, or even death. The real epidemic in America is not measles, chicken pox, or Hepatitis B. It is the skyrocketing rate of autoimmune diseases (asthma, allergies, skin disorders, type-1 diabetes, lupus, irritable bowel syndrome, etc.) and neurological disorders (developmental delays, autism, ADHD, epilepsy and seizures, etc.). The vaccine schedule has tripled since the 1980s and a generation of children are suffering. Why? Because the vaccine market is VERY profitable — annually worth tens of billions in the US alone with exponential growth opportunities. There are 271 new vaccines under development. The government is trying to make ALL vaccines mandatory (53 on the childhood schedule alone, over 130 on the adult schedule) — first for kids, then adults (google) Why don’t you hear about this in the media? Because pharma accounts for at least 40% of advertising dollars — media censorship at it’s best. Pharma also spends billions on marketing their drugs to medical schools, doctors, universities and legislators. Pharma is the second biggest lobby group in Washington DC. Because vaccines are not classified as standard pharmaceutical drugs, they undergo far LESS safety testing and 90% of the studies are funded by pharma, which profits off the vaccine. Brandy Vaughan, a former pharmaceutical representative http://vaccine-injury.info/
Просмотров: 10004 Purpose of Life?
Impressive Channel Sales Case Study
 
01:25
You can talk all you like, but where the real power lies is in the proof. That is why we are happy to share this powerful case study of one of our incentive programmes that delivered massive results for our client. Your business could also benefit, especially if you deal with a 3rd party distributor or re-seller. Once you experience the results, it becomes an integral part of your sales methodology. We have many case studies. Call us and we can set up a meeting to discuss your needs and show you some more great results. http://www.uwiniwin.net/index.php/our-services/performance-improvement
Просмотров: 1337 UwinIwinIncentivesSA
Martin Shkreli Testifies Before Congress and Annoys Congressmen | NBC News
 
01:47
Ex-big pharma executive Martin Shkreli testified at a congressional hearing about the recent rise of drug prices and frustrated committee members. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and our original series Debunker, Flashback, Nerdwatch, and Show Me. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Google+: http://nbcnews.to/PlusNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC Follow NBC News on Pinterest: http://nbcnews.to/PinNBC Martin Shkreli Testifies Before Congress and Annoys Congressmen | NBC News
Просмотров: 127606 NBC News
Nitrogen generator for pharmaceutical industry (subtitles)
 
04:31
http://general-gas.com/ Nitrogen generator GN-4 from General Gas. Used for supply pure nitrogen to mass spectrometer in laboratory. Made in Russia by General Gas.
Просмотров: 76 General Gas
Prescription Drug Pricing: New Solutions
 
02:37:49
Experts from the pharmaceutical, government, academic, medical and health care arena gather at the Johns Hopkins Bloomberg School of Public Health for a symposium on Prescription Drug Pricing. The half day event brings together leaders from the private and public sector with a wide range of perspectives to discuss and formulate policy options to address the prescription drug pricing issue in the U.S.
Dr Jim Willie - post-election insight & predictions - CTM #639
 
02:46:54
Jim Will portrait The man behind the name Jim Willie has experience in three important fields of statistical practice in the 23 years following completion of a PhD in Statistics at Carnegie Mellon University. He spent time since 2001 in a private consulting firm in Pittsburgh, PA. His work included pharmaceutical and medical claim estimation, stratified sampling for consumer packaged goods market share, training seminars in advanced regression models, and consulting toward various other projects within the firm. In August of 2003, he became a low-cost solution at his firm, and since then has focused exclusively on the US and world economies, financial markets, currencies, and the commodity fields. Gold and energy have been a prime focus. Jim spent five years at the corporate headquarters of Staples in suburban Boston in the last half of the 1990 decade. Work focused upon forecasting and sales analysis for their retail business, but also for the catalog and internet business. His retail floor labor scheduling program integrated several forecasts across the entire retail chain of over 1000 stores. Retail models, seasonality estimation, marketing effects, price elasticity analysis, all supported either the forecast process or profit margin enhancement. During his time at Staples, the company quadrupled in revenues and store count nationwide. At Digital Equipment Corporation in suburban Boston, Jim worked for nine years in a unique zero-profit center within the company, one totally dedicated to marketing research on Digital products and the computer industry. Large strategic studies and smaller product studies were completed in the hundreds by a staff of 12. Strategic studies incorporated orthogonal fractional factorial designs, for evaluating various product feature combinations and industry directions. Product studies helped to enhance design and development.All datasets were analyzed exhaustively for useful information on perceptions, preferences, drivers, trends, usage, and demographics. However, extreme errors of judgment by senior executives resulted in the rapid decline in the company, departure of the best and brightest leaders, severe reduction in its workforce, and eventual acquisition by Compaq, then later by Hewlett Packard, which now manages his defined benefit pension. Sadly, many younger people have not even heard of the second largest computer mfg firm behind IBM in the 1980 and 1990 decades.HP took a large portion of Digital’s customer base. Also at Digital, before the marketing research post, Jim worked for five years as a quality control consultant to the manufacturing organizations. He authored a DEC Engineering Specification which was integrated at all 28 mfg plants worldwide. It streamlined the stress testing of units from the assembly lines, with significant savings from reduced test time.Over a seven-year period, its implementation reduced mfg costs corporate-wide by between $250 and $300 million.Those were days of considerable fat in the US mfg arena, however. A few of his colleagues from Digital days remain trusted friends and analysts. About Golden Jackass The Golden Jackass website is designed to inform and instruct in the complex ways of gold, currencies, bonds, interest rates, stocks, commodities, futures, derivatives and the world economy, with no respect shown for inept bankers and economists, whose policies and practices contribute toward the slow motion degradation, if not destruction, of the financial world. The website provides an ongoing source of excellent articles written by other authors, who make significant contributions to the above mentioned topics, in addition to a collection of news briefs filled with critical data. A minimum of tools are also made available for monitoring charts of important series, such as the USDollar, gold, the CRB index, and the US$ money supply. For those who wish to pursue a deeper course, with monthly commentary and essays, highlighted by strategic forecasts, combined with potentially profitable mining and energy stock selections, subscription to the HAT TRICK LETTER is offered to members at the cost of a low recurring fee.
Просмотров: 34340 John B. Wells The ONLY Official CTM Channel
Explainer video Alpen Animation MedTech SC Pharmaceuticals
 
02:04
Alpen Animation is a video production company for highly effective explainer videos. Use our top ranking explainer videos to explain your business, product, app or service. We offer affordable prices. This video was produced for ... to explain "...". ... is offering several advantages and benefits which are described in this video animation. Only professional copywriters who have many years in writing selling copy, will write your script! We want your video to rank highly and to convert. Therefore, before we produce your video, we analyze your market and - more important - what your customers are looking for exactly when they search for your product or service. For example, what keywords are they searching in google and youtube? This way, we can increase the probability that your video will rank highly. Most explainer videos do not respect the "rules" of youtube and google ranking. We do! We keep our animated explainer videos as simple as possible, as we want a maximum of people to understand them. Good explanation videos get the message accross in about 60-90 seconds - anything else is considere to be too long and people won't watch the full length of your video. We have used videos ourselves for more than 15 years in sales and marketing. We know from our own experience how much you can increase your sales by using explainer videos. You can use them not only as web videos and online marketing, but also: - on your customers' webpages - for online stores - for sales presentations and crowdfunding, as kickstarter video - during shows and exhibitions - at the Point of Sales (POS) on digital signage screens A 1 minute video shows and explains according to recent statistics more than 1.8 million words. Just watch the video above and imagine yourself how many words you would need to describe the situation, the emotions, the story. Explainer videos tell a story which will help to sell your product. They are far more enganging and entertaining than just words and people remember a video easier than lenghty verbal descriptions. ALPEN ANIMATION: we will produce your video with passion and give you all the service you expect. We are speaking several languages and have native speaking people in our team for English, Spanish, French, German, Polish, Russian, Ukrainian, Norwegian, Swedish, Italian! this will help you a lot in getting a convincing script. We can offer any style of explainer videos - ideally just send us a video you like and we can adapt. For example: - whiteboard animation explainer video - 2D and 3D animations - comic style - Infographics - Motion Graphics Looking forward to hearing from you, contact frank.metzel@gmail.com for further information. Please subscribe to our channel and send us your comments and how you like or dislike our videos. We are always interested in our viewers' feed-back as this is the only way to improve our explainer videos and our explanations. Visit also: www.alpenanimation.com Looking forward to hearing from you, contact frank.metzel@gmail.com for further information.
Просмотров: 481 AlpenAnimation
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Oral Argument - October 15, 2014
 
59:22
Facts: Sandoz, Inc., (Sandoz) and Mylan Pharmaceuticals, Inc. (Mylan) submitted Abbreviated New Drug Applications (ANDAs) to the Food and Drug Administration (FDA) to produce and market generic versions of Copaxone, a drug used to treat Multiple Sclerosis. Teva Pharmaceuticals USA, Inc., the manufacturer of the original drug, sued Sandoz and Mylan and used two different types of claims that are based on different ways to use molecular weight to distinguish between polymer samples. The district court did not distinguish between the different methods of using molecular weight and held that the claims were not indefinite as Sandoz and Mylan argued. After a bench trial, the district court held that the Sandoz and Mylan products infringed on Teva's patent. The U.S. Court of Appeals for the Federal Circuit held that the district court did not error in holding that the patents were infringed, but that some of the claims had not been effectively shown to be definite. Question: Can a district court's finding of fact in the construction of a patent claim be reviewed de novo , as though for the first time, which the U.S. Court of Appeals for the Federal Circuit requires and did in this case? Conclusion: No. Justice Stephen G. Breyer delivered the opinion for the 7-2 majority. The Court held that a federal appellate court could only overturn a district court's finding of fact if those findings were determined to be "clearly erroneous." Federal Rule of Civil Procedure 52(a)(6) established this standard without any exceptions, and there was no reason to create one in this case. Because the construction of a patent claim is essentially a factual determination, it should be governed by this well-established standard. Therefore, while an appellate court may still review a lower court's construction of a claim de novo , to overturn the lower court's ruling, the appellate court must find that the lower court has made a clear error with respect to the findings of fact. Justice Clarence Thomas wrote a dissent in which he argued that the construction of patent claims deals with questions of law, so Federal Rule of Procedure 52(a)(6), which only applies to questions of fact, is not the controlling standard. Instead, the appellate court was correct to apply a de novo standard of review, which increases uniformity. Justice Thomas wrote that a district court's determination is factual in nature when it deals with the historical fact of the case, as in the case of contracts and deeds, while it is a legal conclusion when it defines rules applicable beyond the specifics of the case at hand, as in the case of statutes. Based on this definition, the construction of patent claims should be considered a question of law. Justice Samuel A. Alito, Jr. joined in the dissent. For more information about this case see: https://www.oyez.org/cases/2014/13-854 Section 1: 00:00:05 Section 2: 00:22:52 Section 3: 00:33:10 Section 4: 00:56:14 PuppyJusticeAutomated videos are created by a program written by Adam Schwalm. This program is available on github here: https://github.com/ALSchwalm/PuppyJusticeAutomated The audio and transcript used in this video is provided by the Chicago-Kent College of Law under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License. See this link for details: https://creativecommons.org/licenses/by-nc/4.0/
Просмотров: 239 PuppyJusticeAutomated
NPPA reduces price of medicines for Diabetes and cancer
 
03:58
Watch this special segment and get to know about the good initiative taken by NPPA by reducing the price of medicines for Diabetes and cancer. To know more watch this full video here. Zee News always stay ahead in bringing current affairs from all the valley of National interest, Politics, Entertainment, Sports and International happenings. We take you to the depth of every matter by providing every small detail and makes you familiar with all the happening around you. Zee News is the highly popular Hindi News channel of India’s largest television network ZMCL. The channel, which has a huge following in India and abroad, has won several prestigious national and international awards. Among its popular programs are - Dr. Subhash Chandra Show: https://goo.gl/fCugXC Daily News and Analysis: https://goo.gl/B8eVsD Manthan: https://goo.gl/6q0wUN Fast n Facts: https://goo.gl/kW2MYV Your daily dose of entertainment: https://goo.gl/ZNEfhw Sports roundup: https://goo.gl/KeeYjf Aapke Sitare: https://goo.gl/X56YSa Bharat Bhagya Vidhata: https://goo.gl/QqJiOV Taal Thok Ke : https://goo.gl/yiV6e7 Subscribe to our channel at https://goo.gl/qKzmWg Check out our website: http://www.zeenews.com Connect with us at our social media handles: Facebook: https://www.facebook.com/ZeeNews Twitter: https://twitter.com/ZeeNews Google Plus: https://plus.google.com/+Zeenews
Просмотров: 220 Zee News
BioMarin Shares Tanked So Far This Year – Here’s What Jim Cramer Says
 
00:36
TheStreet’s Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on shares of BioMarin Pharmaceutical (BMRN). ‘The big bear market that’s still left is in smaller biotech stocks,’ Cramer said. ‘We solved the commodity bear market, the restaurant bear market, the retail bear market. Watch BioMarin, because if it does go higher, maybe people will start recommending all of those companies that are in biotech that have just been crushed.’ The analysts at Robert W. Baird upgraded the stock to outperform from neutral and raised their price target to $110 a share. The stock currently trades near $86 and has fallen 17.4% since the start of the year. The broader S&P 500 has lost 2.5% year-to-date. Subscribe to TheStreetTV on YouTube: http://t.st/TheStreetTV For more content from TheStreet visit: http://thestreet.com Check out all our videos: http://youtube.com/user/TheStreetTV Follow TheStreet on Twitter: http://twitter.com/thestreet Like TheStreet on Facebook: http://facebook.com/TheStreet Follow TheStreet on LinkedIn: http://linkedin.com/company/theStreet Follow TheStreet on Google+: http://plus.google.com/+TheStreet
Просмотров: 211 TheStreet: Investing Strategies
Global Organic Cosmetics Industry 2016 Market Research Report
 
01:04
A study on Global Organic Cosmetics Market its development trends and marketing channels are analyzed as well as valuable sources of guidance and direction for companies and individuals interested in the market. The Global Organic Cosmetics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Organic Cosmetics industry. “Global Organic Cosmetics Industry 2016 Market Research Report″ is now available with eMarketOrg.com at http://emarketorg.com/pro/global-organic-cosmetics-industry-2016-market-research-report/
Просмотров: 107 Jem Fernandez
Redx Pharma CEO on resistant superbugs and pipeline deals
 
08:45
Neil Murray, chief executive of Redx Pharma Plc (LON:REDX), welcomes this week’s UK government report on how to tackle the growing resistance to antibiotics. Statistics reveal that without action there will be 10mln extra deaths at a cost of US$100trn by 2050. Murray says this equates to one person dying every three seconds from resistant infection which is a higher cause of death than cancer is today. Redx is working on multiple treatments to tackle all superbugs. Due to the nature and the severity of the problem Murray and his team anticipated more and large companies returning to the space and “we wanted to be in a position where we had those pipeline assets.” The biotech company is having negotiations about its pipeline and Murray is confident further deals will be secured “in due course.” Murray explains there hasn’t been a new class of antibiotics in a generation, and Redx’s antibacterial compounds represent “potentially that first new class and that’s very exciting.”
Просмотров: 185 Proactive Investors Stocktube
Do You Actually Need A Multivitamin?
 
04:05
The supplement industry is a multi billion dollar revenue stream for thousands of companies. Staggering numbers show supplement sales reached 37 billion dollars in 2015 and that number is constantly growing. A multivitamin is the one of the most common supplements sold since it covers a broad range of vitamins and minerals in a single dose. Trouble is, do you know if the multivitamin is actually helping or hurting you? According to several recent studies, many people are taking too much of particular vitamins, increasing their chances for cancer and heart disease. Here are some examples: • Beta Carotene may increase lung cancer and heart disease • Folic Acid may increase colon polyps • Vitamin E may increase prostate cancer • Selenium may increase prostate cancer With all the ads and recommendations for supplements, what do you choose? The best way to know if you actually need a supplement is to check through lab testing, specifically a Micronutrient test. Learn more about this test at http://www.renuehealth.com/micronutrient-testing/ Finally, choose the right supplements. The supplement industry is unregulated and there are lots of poor quality products being sold with no consistency or oversight in the manufacturing process. Recent reports from consumer reporting agencies show that many top brands in big chain stores were actually nothing but fillers! Talk about throwing money away! Choose reputable supplement companies that operate under pharmaceutical guidelines for quality and consistency. Some of those include Metagenics and Pure Encapsulations. If you are not sure, don't buy it without doing your research. To learn how the ReNue Health Opportunity can help restore your youth and vitality, simply call 937-350-5527 or visit us at http://www.renuehealth.com/
Просмотров: 65 Renue Health
British pound holds firm against USD
 
03:09
While the future of the United Kingdom in the event of a Brexit is being debated by media outlets, pundits and financial market participants, the Office for National Statistics has revealed some encouraging news. Official data released earlier in the day showed that the UK’s manufacturing production posted a stronger-than-expected advance, boosting optimism about the country’s economic outlook. The report indicated that manufacturing production in the UK surged by a seasonally adjusted 2.3 percent in April, beating the forecast for a marginal gain of 0.1 percent. In the previous month, the country’s manufacturing output grew by a mere 0.1 percent. On a year-on-year basis, manufacturing production printed a rise of 0.8 percent following the March decline of 1.9 percent. Analysts had anticipated yet another drop of 1.5 percent in April. Today’s figures also suggest that UK industrial production jumped by 2 percent in April, easily exceeding expectations for a zero gain. In annual terms, the indicator climbed by 1.6 percent after shedding 0.2 percent in March. Such an impressive advance was driven by an increase in the pharmaceutical industry as well as improving car production, aided by stronger domestic demand and robust sales outside the UK. The market absorbed the latest slew of statistics instantly. However, the British pound was rather slow to react to the upbeat data. Bouncing off its daily lows, the cable extended gains, currently trading around 1.4547 levels. Currency strategists point out that the situation is unclear for dollar bulls, who are unsure whether it would be a good idea to purchase the greenback amid the current economic turmoil. As for the pound, with Brexit risks looming in Europe, many traders are hesitant to buy the British pound ahead of the upcoming referendum this month. At present, the most recent Brexit polls suggest that most Britons are ready to vote to leave the European Union, which raises a lot of doubts among investors. At the same time, economists warn market players about the gloomy economic consequences the UK will have to face if it decides to remove itself as a member of the bloc. Therefore, as cautious trading persists, the foreign exchange market is putting in a relatively steady performance without much volatility. https://www.instaforex.com/ru/
Просмотров: 206 InstaForex
Ukrainian elite neighborhood. Real estate in Ukraine.
 
02:23
Elite neighborhood. Good infrastructure. Buy real estate in Ukraine. The average price of apartments in Kiev's secondary market fell by only 2% to US$ 1,174 per square metre (sq. m.) during the year to March 2016. But this represents a massive 67.6% decline from the housing boom's September 2008 peak of US$3,627 per sq. m., based on figures from the S&V Development. Experts predict that house prices will continue to decline in 2016 due to low demand. Yet surprisingly, inflation is down and Ukraine's economy is growing again. Despite the recent armed conflict, despite continued extensive government corruption, Ukraine is doing better than expected. "While no one would confuse today’s market with a housing boom, if you take a quick walk around Kiev’s center, you will see lots of construction activity," says Tim Louzonis of AIM Realty Kiev. The volume of construction in Ukraine rose by 12.5% to UAH 57.5 billion (US$ 2.24 billion) in 2015, according to the State Statistics Service. Residential construction was up by 23.2% to UAH 13.9 billion (US$ 542.6 million), while non-residential construction rose by 10.6% to almost UAH 15 billion (US$ 585.1 million). "Due to the hryvnia devaluation, material and labor costs for developers (mostly based in UAH) have decreased in dollar terms much more than housing prices (which are priced in dollars). So development projects continue despite the current economic malaise – instead of relying on bank financing, most of these developers are able to finance their projects with proceeds from “pre-sales” of apartments fueled by Ukrainians’ in trust in real estate and Kiev’s housing deficit." In the primary market, i.e., newly-built, the average apartment prices also dropped by 2.04% y-o-y to US$ 1,055 per sq. m.. The current average price is 60% lower than June 2008's peak price of US$ 2,638 per sq. m. The massive decline in Ukraine's house prices, which occurred in 2014 and 2015, is attributable to the Ukrainian hryvnia's loss of value due to a series of devaluations over the past two years. This period has been a headache for realtors, with some contracts being cancelled due to buyers' inability to convert currency, while sellers refuse to accept hryvnia. "I think that the downward trend for prices would remain and it will be seen in 2016," said Viktor Nesin, Chair of the Chamber of Realtors of Ukraine. "This will not be a slump, but I think that we will see a fall of 3-5% a month." Nesin added that the predicted price decline is due to low demand, pointing out that Kyiv's property market currently has 300 to 400 transactions per month, compared to 4,000 transactions per month in 2012 and 2013. http://www.globalpropertyguide.com/Europe/Ukraine/Price-History
Просмотров: 357 American in Ukraine